We are live on !
Find out more
Axos Invest Portfolio holdings
AUM
$133M
Turnover
13.64%
1-Year Est. Return
11.38%
This Fund
S&P 500
This Quarter Est. Return
-0.19%
1 Year Est. Return
+11.38%
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$133M
AUM Growth
-$3.68M
(-2.7%)
Cap. Flow
-$2.77M
Cap. Flow % of AUM
Cap. Flow %
-2.08%
Top 10 Holdings %
Top 10 Hldgs %
93.78%
Holding
22
New
2
Increased
5
Reduced
13
Closed
1
Avg Time Held
1.5
years
Top 10 Avg Time Held
1.4
years
Top 20 Avg Time Held
1.5
years
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Virtus Biotech ETF
BBP
|
+$396K |
| 2 |
Vanguard S&P 500 ETF
VOO
|
+$229K |
| 3 |
Panagram BBB-B CLO ETF
CLOZ
|
+$219K |
| 4 |
Invesco S&P 500 Momentum ETF
SPMO
|
+$25K |
| 5 |
State Street SPDR Portfolio Emerging Markets ETF
SPEM
|
+$23.9K |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Vanguard Morningstar Total Stock Market ETF
VTI
|
+$1.2M |
| 2 |
Vanguard FTSE Developed Markets ETF
VEA
|
+$939K |
| 3 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$291K |
| 4 |
Vanguard Intermediate-Term Treasury ETF
VGIT
|
+$221K |
| 5 |
Genter Capital Taxable Quality Intermediate ETF
GENT
|
+$186K |
Sector Composition
| Rank | Sector | Weight |
|---|
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
|
1
Vanguard S&P 500 ETF
VOO
$1.05T
| $40.8M | 30.69% |
58,217
+328
| +0.6% | +$229K |
2025 Q3
4 quarters
|
|
|
2
Vanguard FTSE Developed Markets ETF
VEA
$229B
| $32.1M | 24.17% |
454,974
-13,093
| -3% | -$939K |
2024 Q3
8 quarters
|
|
|
3
Vanguard Morningstar Total Stock Market ETF
VTI
$691B
| $21.2M | 15.97% |
56,737
-3,206
| -5% | -$1.2M |
2024 Q3
8 quarters
|
|
|
4
Genter Capital Taxable Quality Intermediate ETF
GENT
$111M
| $7.01M | 5.27% |
707,819
-18,337
| -3% | -$186K |
2025 Q4
3 quarters
|
|
|
5
Vanguard Intermediate-Term Treasury ETF
VGIT
$40.5B
| $5.76M | 4.33% |
101,600
-3,808
| -4% | -$221K |
2024 Q3
8 quarters
|
|
6
iShares TIPS Bond ETF
TIP
$14.4B
| $5.03M | 3.79% |
48,377
-1,360
| -3% | -$145K |
2024 Q3
8 quarters
|
|
|
7
State Street SPDR Portfolio Emerging Markets ETF
SPEM
$16.3B
| $5.02M | 3.77% |
96,931
+460
| +0.5% | +$23.9K |
2025 Q3
4 quarters
|
|
8
State Street SPDR Bloomberg Short Term High Yield Bond ETF
SJNK
$4.34B
| $2.68M | 2.02% |
110,474
-2,409
| -2% | -$59.7K |
2024 Q3
8 quarters
|
|
9
Vanguard Short-Term Corporate Bond ETF
VCSH
$45.5B
| $2.52M | 1.9% |
32,625
-1,381
| -4% | -$108K |
2024 Q3
8 quarters
|
|
10
Vanguard Real Estate ETF
VNQ
$38.6B
| $2.49M | 1.88% |
27,810
-547
| -2% | -$53K |
2024 Q3
8 quarters
|
|
11
Schwab International Equity ETF
SCHF
$67.6B
| $1.78M | 1.34% |
64,810
-4,242
| -6% | -$118K |
2024 Q3
8 quarters
|
|
12
Vanguard FTSE Emerging Markets ETF
VWO
$119B
| $1.71M | 1.29% |
28,876
-2,054
| -7% | -$123K |
2024 Q3
8 quarters
|
|
13
Schwab US Broad Market ETF
SCHB
$44.4B
| $1.28M | 0.96% |
43,750
-5,441
| -11% | -$160K |
2024 Q3
8 quarters
|
|
14
Genter Capital Municipal Quality Intermediate ETF
GENM
$34M
| $678K | 0.51% |
68,671
+2,020
| +3% | +$20.5K |
2025 Q3
4 quarters
|
|
15
State Street Technology Select Sector SPDR ETF
XLK
$115B
| $639K | 0.48% |
3,263
+35
| +1% | +$6.46K |
2026 Q2
1 quarter
|
|
16
iShares Core MSCI Emerging Markets ETF
IEMG
$146B
| $578K | 0.43% |
7,119
-365
| -5% | -$29.4K |
2024 Q3
8 quarters
|
|
|
17
Virtus Biotech ETF
BBP
$133M
| $409K | 0.31% |
+3,875
| New | +$396K |
2026 Q3
0 quarters
|
|
|
18
Invesco S&P 500 Momentum ETF
SPMO
$21.1B
| $338K | 0.25% |
2,233
+168
| +8% | +$25K |
2025 Q4
3 quarters
|
|
19
Vanguard Information Technology ETF
VGT
$140B
| $335K | 0.25% |
2,666
| – | – |
2024 Q3
8 quarters
|
|
20
Vanguard Intermediate-Term Corporate Bond ETF
VCIT
$67.8B
| $290K | 0.22% |
3,708
-695
| -16% | -$56.2K |
2024 Q3
8 quarters
|
|
|
21
Panagram BBB-B CLO ETF
CLOZ
$671M
| $220K | 0.17% |
+8,348
| New | +$219K |
2026 Q3
0 quarters
|
|
|
22
State Street SPDR S&P 500 ETF Trust
SPY
$803B
| – | – |
-390
| Closed | -$291K | – |
|
Similar funds
Axos Invest's Q3 2026 Portfolio in Review
As of Q3 2026, Axos Invest held 22 positions worth $133M, down 2.7% from $137M the previous quarter. Its ten largest holdings account for 94% of the portfolio.
Axos Invest's Q3 2026 filing shows 2 new, 5 increased, 13 reduced and 1 closed positions. Its largest new stake was Virtus Biotech ETF: 3,875 shares worth $409K. The largest sale was Vanguard Morningstar Total Stock Market ETF, an estimated $1.2M.
- Axos Invest's largest Q3 2026 buy was Virtus Biotech ETF: 3,875 shares worth $409K.
- Axos Invest added most to Vanguard S&P 500 ETF in Q3 2026, an estimated $229K increase.
- Axos Invest's biggest Q3 2026 reduction was Vanguard Morningstar Total Stock Market ETF, cutting an estimated $1.2M.
- Axos Invest fully exited State Street SPDR S&P 500 ETF Trust in Q3 2026, selling an estimated $291K.
- Axos Invest's ten largest holdings make up 94% of its $133M portfolio in Q3 2026.
- Axos Invest opened 2 new positions and closed 1 in Q3 2026.
- Axos Invest's portfolio value fell 2.7% quarter-over-quarter to $133M.
Based on Axos Invest's 13F filing for Q3 2026, filed 21 Oct 2026.